Endologix Inc
ELGX
ELGX was delisted on the 15th of July, 2020.
99 hedge funds and large institutions have $56M invested in Endologix Inc in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 21 closing their positions.
24% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 25
5% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 21
1% less funds holding
Funds holding: 100 → 99 (-1)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
63% less capital invested
Capital invested by funds: $152M → $56M (-$95.9M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$931K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$863K |
| 3 |
BlackRock
New York
|
+$567K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$553K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$553K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$14.2M |
| 2 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$2.14M |
| 3 |
Millennium Management
New York
|
-$745K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$695K |
| 5 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$588K |
ELGX Hedge Fund Activity: Q4 2018 in Review
99 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Endologix Inc (ELGX) for Q4 2018, worth a combined $56M — down 63% from $152M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of ELGX and 20 opened new positions — a net loss of 1 holder — while 25 trimmed existing stakes and 31 added.
The largest buyer was JP Morgan Chase, adding an estimated $931K. The largest seller was PFM Health Sciences, exiting entirely with an estimated $14.2M sold.
- 99 institutional investors held Endologix Inc (ELGX) as of Q4 2018, down from 100 in Q3 2018.
- Funds reported $56M of Endologix Inc stock for Q4 2018, down 63% quarter-over-quarter.
- 20 funds opened new Endologix Inc positions in Q4 2018 and 21 closed out, a net change of -1 holder.
- The largest Endologix Inc buyer in Q4 2018 was JP Morgan Chase, an estimated $931K added.
- The largest Endologix Inc seller in Q4 2018 was PFM Health Sciences, an estimated $14.2M sold.
Based on aggregated 13F filings for Q4 2018.